JCVVX
Price
$25.97
Change
-$0.01 (-0.04%)
Updated
Sep 5 closing price
Net Assets
615.33M
VVIAX
Price
$71.19
Change
-$0.24 (-0.34%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

JCVVX vs VVIAX

Header iconJCVVX vs VVIAX Comparison
Open Charts JCVVX vs VVIAXBanner chart's image
JHancock Classic Value R5
Price$25.97
Change-$0.01 (-0.04%)
VolumeN/A
Net Assets615.33M
Vanguard Value Index Adm
Price$71.19
Change-$0.24 (-0.34%)
VolumeN/A
Net Assets202.84B
JCVVX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JCVVX vs. VVIAX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JCVVX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 203B vs. JCVVX (615M). JCVVX pays higher dividends than VVIAX: JCVVX (2.76) vs VVIAX (2.10). JCVVX was incepted earlier than VVIAX: JCVVX (16 years) vs VVIAX (25 years). JCVVX (0.85) is less costly to investors than VVIAX (0.05). JCVVX is a more actively managed with annual turnover of: 29.00 vs. VVIAX (9.00). JCVVX has a lower initial minimum investment than VVIAX: JCVVX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.74 vs. JCVVX (-25.15). VVIAX return over 5 years is better than : 70.16 vs. JCVVX (9.39).
JCVVXVVIAXJCVVX / VVIAX
Total Expense Ratio0.840.051,680%
Annual Report Gross Expense Ratio0.850.051,700%
Fund Existence16 years25 years-
Gain YTD9.7637.850124%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets615M203B0%
Annual Yield % from dividends2.762.10131%
Returns for 1 year-25.157.74-325%
Returns for 3 years-24.4136.61-67%
Returns for 5 years9.3970.1613%
Returns for 10 years18.22131.6114%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMCX7.560.20
+2.72%
AMC Networks
INMB1.950.03
+1.56%
INmune Bio
ACGLN18.080.19
+1.06%
Arch Capital Group Ltd
ARDX6.52-0.05
-0.76%
Ardelyx
HQY91.48-6.22
-6.37%
HealthEquity